Discovery of novel NLRP3 inhibitors enabled by a high-throughput screen

被引：0

作者：

Dorich, Stephane ^{[1
]}

Auger, Anick ^{[1
]}

Wang, Li ^{[2
]}

Burch, Jason ^{[1
]}

Pellerin, Charles ^{[1
]}

Chan, Silas ^{[2
]}

Raymond, Marianne ^{[1
]}

Zhang, Lingling ^{[2
]}

Chefson, Amandine ^{[1
]}

Germain, Marie-Anne ^{[1
]}

Jananji, Silvana ^{[1
]}

Dumais, Valerie ^{[1
]}

Gaudreault, Samuel ^{[1
]}

Caron, Alexandre ^{[1
]}

Dumas-Berube, Emilie ^{[1
]}

Crackower, Michael. A. ^{[2
]}

机构：

[1] Ventus Therapeut Inc, 4800 Rue Levy, St Laurent, PQ H4R 2P1, Canada

[2] Ventus Therapeut US Inc, 100 Beaver St,Suite 201, Waltham, MA 02453 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2025年 / 122卷

关键词：

NLRP3; inhibitors; High-throughput screen (HTS); Scintillation proximity assay (SPA); Brain penetrant; Furan; Pharmacodynamic model; INFLAMMASOME;

D O I：

10.1016/j.bmcl.2025.130184

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

NLRP3 is a key regulator of the innate immune system involved in sensing a variety of pathogen and danger signals. Priming and activation of NLRP3 leads to the release and maturation of pro-inflammatory cytokines, as well as gasdermin D-mediated cell death. Inhibition of dysregulated NLRP3 activity has been associated with promising therapeutic opportunities for a variety of systemic and neurological diseases including atherosclerosis and Parkinson's disease. Herein, we discuss how a high-throughput screen (HTS) allowed us to discover new chemical scaffolds that specifically bind to NLRP3 and inhibit its function in a selective manner. We also describe how an enantiomer of HTS hit 5, compound 11, demonstrated in vivo inhibition of NLRP3.

引用

页数：7

共 50 条

[21] Discovery of Novel NLRP3 Inflammasome Inhibitors Composed of an Oxazole Scaffold Bearing an Acylsulfamide
Ohba, Yusuke
Adachi, Kaoru
Furukawa, Takayuki
Nishimaru, Tatsuya
Sakurai, Kentaro
Masuo, Ritsuki
Inami, Tasuku
Orita, Takuya
Akai, Shota
Adachi, Tsuyoshi
Usui, Kenji
Hamada, Yuji
Mori, Mutsuki
Kurimoto, Takafumi
Wakashima, Takeshi
Akiyama, Yoshiyuki
Miyazaki, Susumu
Noji, Satoru
ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (12): : 1833 - 1838
[22] Discovery of novel Leishmania major trypanothione synthetase inhibitors by high-throughput screening
Phan, Trong-Nhat
Park, Kyuho Paul
Benitez, Diego
Comini, Marcelo A.
Shum, David
No, Joo Hwan
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 637 : 308 - 313
[23] High-throughput discovery of novel small-molecule inhibitors of acid Ceramidase
Aseeri, Mazen
Abad, Jose Luis
Delgado, Antonio
Fabrias, Gemma
Triola, Gemma
Casas, Josefina
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01) : 343 - 348
[24] Development of a novel high-throughput screening assay for rapid discovery of lipoxygenase inhibitors
Deschamps, JD
Shah, RR
Holman, TR
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U149 - U150
[25] Discovery of novel oridonin sulfamide derivatives as potent NLRP3 inhibitors by a visible-light photocatalysis-enabled peripheral editing
Li, Mochenxuan
Wang, Chuanhao
Ye, Shuang
Li, Wei
Zhang, Yanming
Yan, Jianyu
Wang, Yongchuang
Yang, Hang
Wu, Yuelin
Zhang, Yongqiang
Zhang, Huojun
Miao, Zhenyuan
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 99
[26] Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors
Velcicky, Juraj
Janser, Philipp
Gommermann, Nina
Brenneisen, Silke
Ilic, Slavica
Vangrevelinghe, Eric
Stiefl, Nikolaus
Boettcher, Andreas
Arnold, Christelle
Malinverni, Claire
Dawson, Janet
Murgasova, Renata
Desrayaud, Sandrine
Beltz, Karen
Hinniger, Alexandra
Dekker, Carien
Farady, Christopher J.
Mackay, Angela
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (02) : 1544 - 1562
[27] Recent Progress on the Discovery of NLRP3 Inhibitors and their Therapeutic Potential
Su, Ma
Wang, Weiwei
Liu, Feng
Li, Huanqiu
CURRENT MEDICINAL CHEMISTRY, 2021, 28 (03) : 569 - 582
[28] NLRP3 Inflammasome Inhibitors for Antiepileptogenic Drug Discovery and Development
Haque, Inamul
Thapa, Pritam
Burns, Douglas M.
Zhou, Jianping
Sharma, Mukut
Sharma, Ram
Singh, Vikas
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
[29] High-throughput discovery of novel developmental phenotypes
Dickinson, Mary E.
Flenniken, Ann M.
Ji, Xiao
Teboul, Lydia
Wong, Michael D.
White, Jacqueline K.
Meehan, Terrence F.
Weninger, Wolfgang J.
Westerberg, Henrik
Adissu, Hibret
Baker, Candice N.
Bower, Lynette
Brown, James M.
Caddle, L. Brianna
Chiani, Francesco
Clary, Dave
Cleak, James
Daly, Mark J.
Denegre, James M.
Doe, Brendan
Dolan, Mary E.
Edie, Sarah M.
Fuchs, Helmut
Gailus-Durner, Valerie
Galli, Antonella
Gambadoro, Alessia
Gallegos, Juan
Guo, Shiying
Horner, Neil R.
Hsu, Chih-Wei
Johnson, Sara J.
Kalaga, Sowmya
Keith, Lance C.
Lanoue, Louise
Lawson, Thomas N.
Lek, Monkol
Mark, Manuel
Arschall, Susan M.
Mason, Jeremy
McElwee, Melissa L.
Newbigging, Susan
Nutter, Lauryl M. J.
Peterson, Kevin A.
Ramirez-Solis, Ramiro
Rowland, Douglas J.
Ryder, Edward
Samocha, Kaitlin E.
Seavitt, John R.
Selloum, Mohammed
Szoke-Kovacs, Zsombor
NATURE, 2016, 537 (7621) : 508 - +
[30] High-Throughput Platform for Novel Reaction Discovery
Lu, Xiao
Luo, Zhiji
Huang, Ruili
Lo, Donald C.
Huang, Wenwei
CHEMISTRY-A EUROPEAN JOURNAL, 2022, 28 (50)

← 1 2 3 4 5 →